 | • レポートコード：GIR201114791 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、PD-L1バイオマーカー検査の世界市場を調査対象にし、PD-L1バイオマーカー検査の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（PD-L1（22C3）、PD-L1（28-8）、PD-L1（SP142）、PD-L1（SP263）、その他）、用途別分析（病院、診断センター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Agilent Technologies、Innovent、Bristol-Myers Squibb、Roche、Regeneron、Merck、Junshi Biosciences、Ono Pharmaceutical、AstraZeneca、Hengrui Medicine ・企業別売上、市場シェア ・PD-L1バイオマーカー検査の地域別市場分析 ・PD-L1バイオマーカー検査の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・PD-L1バイオマーカー検査のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・PD-L1バイオマーカー検査のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・PD-L1バイオマーカー検査の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・PD-L1バイオマーカー検査の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・PD-L1バイオマーカー検査の種類別市場規模2015-2020：PD-L1（22C3）、PD-L1（28-8）、PD-L1（SP142）、PD-L1（SP263）、その他 ・PD-L1バイオマーカー検査の用途別市場規模2015-2020：病院、診断センター、その他 ・PD-L1バイオマーカー検査の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The PD-L1 Biomarker Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global PD-L1 Biomarker Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 42.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 2859.9 million by 2025, from USD 700.3 million in 2019.
Market segmentation
PD-L1 Biomarker Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, PD-L1 Biomarker Testing market has been segmented into:
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
By Application, PD-L1 Biomarker Testing has been segmented into:
Hospital
Diagnostic Center
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global PD-L1 Biomarker Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level PD-L1 Biomarker Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global PD-L1 Biomarker Testing market.
The report offers in-depth assessment of the growth and other aspects of the PD-L1 Biomarker Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and PD-L1 Biomarker Testing Market Share Analysis
PD-L1 Biomarker Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, PD-L1 Biomarker Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the PD-L1 Biomarker Testing sales, revenue and market share for each player covered in this report.
The major players covered in PD-L1 Biomarker Testing are:
Agilent Technologies
Innovent
Bristol-Myers Squibb
Roche
Regeneron
Merck
Junshi Biosciences
Ono Pharmaceutical
AstraZeneca
Hengrui Medicine
Among other players domestic and global, PD-L1 Biomarker Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 PD-L1 Biomarker Testing Market Overview
1.1 Product Overview and Scope of PD-L1 Biomarker Testing
1.2 Classification of PD-L1 Biomarker Testing by Type
1.2.1 Global PD-L1 Biomarker Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global PD-L1 Biomarker Testing Revenue Market Share by Type in 2019
1.2.3 PD-L1 (22C3)
1.2.4 PD-L1(28-8)
1.2.5 PD-L1 (SP142)
1.2.6 PD-L1 (SP263)
1.2.7 Other
1.3 Global PD-L1 Biomarker Testing Market by Application
1.3.1 Overview: Global PD-L1 Biomarker Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Global PD-L1 Biomarker Testing Market by Regions
1.4.1 Global PD-L1 Biomarker Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of PD-L1 Biomarker Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) PD-L1 Biomarker Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) PD-L1 Biomarker Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PD-L1 Biomarker Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) PD-L1 Biomarker Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PD-L1 Biomarker Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies SWOT Analysis
2.1.4 Agilent Technologies Product and Services
2.1.5 Agilent Technologies PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Innovent
2.2.1 Innovent Details
2.2.2 Innovent Major Business
2.2.3 Innovent SWOT Analysis
2.2.4 Innovent Product and Services
2.2.5 Innovent PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Regeneron
2.5.1 Regeneron Details
2.5.2 Regeneron Major Business
2.5.3 Regeneron SWOT Analysis
2.5.4 Regeneron Product and Services
2.5.5 Regeneron PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Product and Services
2.6.4 Merck PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Junshi Biosciences
2.7.1 Junshi Biosciences Details
2.7.2 Junshi Biosciences Major Business
2.7.3 Junshi Biosciences Product and Services
2.7.4 Junshi Biosciences PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Ono Pharmaceutical
2.8.1 Ono Pharmaceutical Details
2.8.2 Ono Pharmaceutical Major Business
2.8.3 Ono Pharmaceutical Product and Services
2.8.4 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Product and Services
2.9.4 AstraZeneca PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hengrui Medicine
2.10.1 Hengrui Medicine Details
2.10.2 Hengrui Medicine Major Business
2.10.3 Hengrui Medicine Product and Services
2.10.4 Hengrui Medicine PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global PD-L1 Biomarker Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 PD-L1 Biomarker Testing Players Market Share
3.2.2 Top 10 PD-L1 Biomarker Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global PD-L1 Biomarker Testing Revenue and Market Share by Regions
4.2 North America PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
4.3 Europe PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
4.5 South America PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
5 North America PD-L1 Biomarker Testing Revenue by Countries
5.1 North America PD-L1 Biomarker Testing Revenue by Countries (2015-2020)
5.2 USA PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
5.3 Canada PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
6 Europe PD-L1 Biomarker Testing Revenue by Countries
6.1 Europe PD-L1 Biomarker Testing Revenue by Countries (2015-2020)
6.2 Germany PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
6.3 UK PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
6.4 France PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
6.5 Russia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
6.6 Italy PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific PD-L1 Biomarker Testing Revenue by Countries
7.1 Asia-Pacific PD-L1 Biomarker Testing Revenue by Countries (2015-2020)
7.2 China PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
7.3 Japan PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
7.4 Korea PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
7.5 India PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
8 South America PD-L1 Biomarker Testing Revenue by Countries
8.1 South America PD-L1 Biomarker Testing Revenue by Countries (2015-2020)
8.2 Brazil PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue PD-L1 Biomarker Testing by Countries
9.1 Middle East & Africa PD-L1 Biomarker Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
9.3 UAE PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global PD-L1 Biomarker Testing Revenue and Market Share by Type (2015-2020)
10.2 Global PD-L1 Biomarker Testing Market Forecast by Type (2019-2024)
10.3 PD-L1 (22C3) Revenue Growth Rate (2015-2025)
10.4 PD-L1(28-8) Revenue Growth Rate (2015-2025)
10.5 PD-L1 (SP142) Revenue Growth Rate (2015-2025)
10.6 PD-L1 (SP263) Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global PD-L1 Biomarker Testing Market Segment by Application
11.1 Global PD-L1 Biomarker Testing Revenue Market Share by Application (2015-2020)
11.2 PD-L1 Biomarker Testing Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Diagnostic Center Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global PD-L1 Biomarker Testing Market Size Forecast (2021-2025)
12.1 Global PD-L1 Biomarker Testing Market Size Forecast (2021-2025)
12.2 Global PD-L1 Biomarker Testing Market Forecast by Regions (2021-2025)
12.3 North America PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
12.4 Europe PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
12.6 South America PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global PD-L1 Biomarker Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global PD-L1 Biomarker Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market PD-L1 Biomarker Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global PD-L1 Biomarker Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Agilent Technologies Corporate Information, Location and Competitors
Table 7. Agilent Technologies PD-L1 Biomarker Testing Major Business
Table 8. Agilent Technologies PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 9. Agilent Technologies SWOT Analysis
Table 10. Agilent Technologies PD-L1 Biomarker Testing Product and Solutions
Table 11. Agilent Technologies PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Innovent Corporate Information, Location and Competitors
Table 13. Innovent PD-L1 Biomarker Testing Major Business
Table 14. Innovent PD-L1 Biomarker Testing Total Revenue (USD Million) (2018-2019)
Table 15. Innovent SWOT Analysis
Table 16. Innovent PD-L1 Biomarker Testing Product and Solutions
Table 17. Innovent PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 19. Bristol-Myers Squibb PD-L1 Biomarker Testing Major Business
Table 20. Bristol-Myers Squibb PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 21. Bristol-Myers Squibb SWOT Analysis
Table 22. Bristol-Myers Squibb PD-L1 Biomarker Testing Product and Solutions
Table 23. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Roche Corporate Information, Location and Competitors
Table 25. Roche PD-L1 Biomarker Testing Major Business
Table 26. Roche PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 27. Roche SWOT Analysis
Table 28. Roche PD-L1 Biomarker Testing Product and Solutions
Table 29. Roche PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Regeneron Corporate Information, Location and Competitors
Table 31. Regeneron PD-L1 Biomarker Testing Major Business
Table 32. Regeneron PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 33. Regeneron SWOT Analysis
Table 34. Regeneron PD-L1 Biomarker Testing Product and Solutions
Table 35. Regeneron PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Merck Corporate Information, Location and Competitors
Table 37. Merck PD-L1 Biomarker Testing Major Business
Table 38. Merck PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 39. Merck SWOT Analysis
Table 40. Merck PD-L1 Biomarker Testing Product and Solutions
Table 41. Merck PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Junshi Biosciences Corporate Information, Location and Competitors
Table 43. Junshi Biosciences PD-L1 Biomarker Testing Major Business
Table 44. Junshi Biosciences PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 45. Junshi Biosciences SWOT Analysis
Table 46. Junshi Biosciences PD-L1 Biomarker Testing Product and Solutions
Table 47. Junshi Biosciences PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Ono Pharmaceutical Corporate Information, Location and Competitors
Table 49. Ono Pharmaceutical PD-L1 Biomarker Testing Major Business
Table 50. Ono Pharmaceutical PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 51. Ono Pharmaceutical SWOT Analysis
Table 52. Ono Pharmaceutical PD-L1 Biomarker Testing Product and Solutions
Table 53. Ono Pharmaceutical PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. AstraZeneca Corporate Information, Location and Competitors
Table 55. AstraZeneca PD-L1 Biomarker Testing Major Business
Table 56. AstraZeneca PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 57. AstraZeneca SWOT Analysis
Table 58. AstraZeneca PD-L1 Biomarker Testing Product and Solutions
Table 59. AstraZeneca PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Hengrui Medicine Corporate Information, Location and Competitors
Table 61. Hengrui Medicine PD-L1 Biomarker Testing Major Business
Table 62. Hengrui Medicine PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)
Table 63. Hengrui Medicine SWOT Analysis
Table 64. Hengrui Medicine PD-L1 Biomarker Testing Product and Solutions
Table 65. Hengrui Medicine PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global PD-L1 Biomarker Testing Revenue (Million USD) by Players (2015-2020)
Table 67. Global PD-L1 Biomarker Testing Revenue Share by Players (2015-2020)
Table 68. Global PD-L1 Biomarker Testing Revenue (Million USD) by Regions (2015-2020)
Table 69. Global PD-L1 Biomarker Testing Revenue Market Share by Regions (2015-2020)
Table 70. North America PD-L1 Biomarker Testing Revenue by Countries (2015-2020)
Table 71. North America PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)
Table 72. Europe PD-L1 Biomarker Testing Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific PD-L1 Biomarker Testing Revenue (Million USD) by Countries (2015-2020)
Table 74. South America PD-L1 Biomarker Testing Revenue by Countries (2015-2020)
Table 75. South America PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa PD-L1 Biomarker Testing Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)
Table 78. Global PD-L1 Biomarker Testing Revenue (Million USD) by Type (2015-2020)
Table 79. Global PD-L1 Biomarker Testing Revenue Share by Type (2015-2020)
Table 80. Global PD-L1 Biomarker Testing Revenue Forecast by Type (2021-2025)
Table 81. Global PD-L1 Biomarker Testing Revenue by Application (2015-2020)
Table 82. Global PD-L1 Biomarker Testing Revenue Share by Application (2015-2020)
Table 83. Global PD-L1 Biomarker Testing Revenue Forecast by Application (2021-2025)
Table 84. Global PD-L1 Biomarker Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. PD-L1 Biomarker Testing Picture
Figure 2. Global PD-L1 Biomarker Testing Revenue Market Share by Type in 2019
Figure 3. PD-L1 (22C3) Picture
Figure 4. PD-L1(28-8) Picture
Figure 5. PD-L1 (SP142) Picture
Figure 6. PD-L1 (SP263) Picture
Figure 7. Other Picture
Figure 8. PD-L1 Biomarker Testing Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Diagnostic Center Picture
Figure 11. Others Picture
Figure 12. Global PD-L1 Biomarker Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global PD-L1 Biomarker Testing Revenue Share by Players in 2019
Figure 20. Global Top 5 Players PD-L1 Biomarker Testing Revenue Market Share in 2019
Figure 21. Global Top 10 Players PD-L1 Biomarker Testing Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global PD-L1 Biomarker Testing Revenue Market Share by Regions (2015-2020)
Figure 25. Global PD-L1 Biomarker Testing Revenue Market Share by Regions in 2018
Figure 26. North America PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 27. Europe PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 29. South America PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 31. North America PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)
Figure 32. North America PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019
Figure 33. USA PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 34. Canada PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 35. Mexico PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 36. Europe PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)
Figure 37. Europe PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019
Figure 38. Germany PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 39. UK PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 40. France PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 41. Russia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 42. Italy PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019
Figure 45. China PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 46. Japan PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 47. Korea PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 48. India PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 50. South America PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)
Figure 51. South America PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019
Figure 52. Brazil PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 53. Argentina PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 57. UAE PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 58. Egypt PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 59. South Africa PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)
Figure 60. Global PD-L1 Biomarker Testing Revenue Share by Type (2015-2020)
Figure 61. Global PD-L1 Biomarker Testing Revenue Share by Type in 2019
Figure 62. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2021-2025)
Figure 63. Global PD-L1 (22C3) Revenue Growth Rate (2015-2020)
Figure 64. Global PD-L1(28-8) Revenue Growth Rate (2015-2020)
Figure 65. Global PD-L1 (SP142) Revenue Growth Rate (2015-2020)
Figure 66. Global PD-L1 (SP263) Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global PD-L1 Biomarker Testing Revenue Share by Application (2015-2020)
Figure 69. Global PD-L1 Biomarker Testing Revenue Share by Application in 2019
Figure 70. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Diagnostic Center Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global PD-L1 Biomarker Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global PD-L1 Biomarker Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
Figure 78. Europe PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
Figure 80. South America PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
PD-L1バイオマーカー検査プラットフォームの世界市場 2020年 Market Overview The PD-L1 Biomarker Testing Platform market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- ボーカルバイオマーカーの世界市場 2020年 Market Overview The global Vocal Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vocal Biomarker market report…
- マルチプレックスバイオマーカーイメージングの世界市場 2020年 Market Overview The global Multiplex Biomarker Imaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Multiplex Biomark…
- 液体生検用循環バイオマーカーの世界市場 2020年 Market Overview The global Circulating Biomarker for Liquid Biopsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Circu…
- 腫瘍バイオマーカー検査の世界市場 2020年 Market Overview The global Tumor Biomarker Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Biomarker Test mar…